| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00442082 |
| P698 | PubMed publication ID | 7173260 |
| P2093 | author name string | W Lehnert | |
| J Uy | |||
| M Kiessling | |||
| N Böhm | |||
| P2860 | cites work | Oxidative phosphorylation accompanying oxidation of short-chain fatty acids by rat-liver mitochondria | Q41889559 |
| Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst--the concept of infantile obstructive cholangiopathy | Q55061602 | ||
| Studies on the Effects of Saturated and Unsaturated Short-Chain Monocarboxylic Acids on the Energy Metabolism of Rat Liver Mitochondria | Q66976098 | ||
| Glutaric aciduria type II: Report on a previously undescribed metabolic disorder | Q67432285 | ||
| Glutaric aciduria Type II | Q71188531 | ||
| Biochemical studies in a patient with defects in the metabolism of acyl‐CoA and sarcosine: Another possible case of glutaric aciduria type II | Q72618623 | ||
| PATHOGENESIS OF POLYCYSTIC KIDNEYS. HISTORICAL SURVEY | Q76722087 | ||
| P433 | issue | 1 | |
| P921 | main subject | dehydrogenation | Q898262 |
| Glutaric aciduria | Q5572455 | ||
| P304 | page(s) | 60-65 | |
| P577 | publication date | 1982-09-01 | |
| P1433 | published in | European Journal of Pediatrics | Q15755736 |
| P1476 | title | Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two newborn brothers. II. Morphology and pathogenesis | |
| P478 | volume | 139 |
| Q49239818 | A cleavage product of Polycystin-1 is a mitochondrial matrix protein that affects mitochondria morphology and function when heterologously expressed |
| Q24675345 | Absence makes the search grow longer |
| Q28251926 | Cardiomyopathy in multiple Acyl-CoA dehydrogenase deficiency: a clinico-pathological correlation and review of literature |
| Q48914552 | Cerebral dysgeneses secondary to metabolic disorders in fetal life |
| Q34207192 | Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency |
| Q39160975 | Clinical and pathological study of three Tunisian siblings with L-2-hydroxyglutaric aciduria |
| Q59619487 | Congenital anomalies in glutaric aciduria type 2 |
| Q51986799 | Congenital hydranencephalic-hydrocephalic syndrome associated with mitochondrial dysfunction. |
| Q48696636 | Congenital hydranencephalic-hydrocephalic syndrome with proliferative vasculopathy: a possible relation with mitochondrial dysfunction. |
| Q70673785 | Cystic kidneys. Genetics, pathologic anatomy, clinical picture, and prenatal diagnosis |
| Q80633658 | Cystic renal dysplasia as a leading sign of inherited metabolic disease |
| Q39505161 | Developmental genetics |
| Q39757600 | Disorders of neuronal migration |
| Q36753925 | Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease |
| Q70499026 | Glutaric acidaemia type II (multiple acyl-CoA dehydrogenation deficiency) |
| Q71228364 | Glutaric acidemia type II: a form with deleterious intrauterine effects |
| Q72746230 | Glutaric aciduria type II: biochemical investigation and treatment of a child diagnosed prenatally |
| Q38612836 | Inborn errors of amino acid and fatty acid metabolism with hypoglycemia as a major clinical manifestation |
| Q70337865 | Lethal multiple acyl-CoA dehydrogenation deficiency with dysmorphic features |
| Q40473100 | Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys. |
| Q35188898 | Malformations of cortical development: clinical features and genetic causes |
| Q37468328 | Mechanisms underlying metabolic and neural defects in zebrafish and human multiple acyl-CoA dehydrogenase deficiency (MADD). |
| Q28533885 | Multi-organ abnormalities and mTORC1 activation in zebrafish model of multiple acyl-CoA dehydrogenase deficiency |
| Q34499444 | Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4α as a disease modifier. |
| Q42747907 | Newborn Screening for Glutaric Aciduria-II: The New England Experience |
| Q37938722 | Newborn screening and renal disease: where we have been; where we are now; where we are going |
| Q37254022 | Organic acidurias: a review. Part 1. |
| Q48713528 | Pathology of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation |
| Q30828370 | Polymicrogyria: a common and heterogeneous malformation of cortical development |
| Q72576210 | Prenatal diagnosis of dysmorphic neonatal-lethal type II glutaricaciduria |
| Q42255456 | Prenatal diagnosis of glutaric aciduria type II by direct chemical analysis of dicarboxylic acids in amniotic fluid |
| Q33688367 | Recognition and management of fatty acid oxidation defects: a series of 107 patients. |
| Q77958586 | Sibs diagnosed prenatally with situs inversus totalis, renal and pancreatic dysplasia, and cysts: a new syndrome? |
| Q69606585 | Striatal degeneration in glutaric acidaemia type II |
| Q48144568 | Symmetric hypoplasia of the temporal cerebral lobes in an infant with glutaric aciduria type II (multiple acyl-coenzyme A dehydrogenase deficiency). |
| Q40167487 | The cerebrohepatorenal syndrome of Zellweger, morphologic and metabolic aspects |
| Q28290744 | The inborn errors of mitochondrial fatty acid oxidation |
| Q35808261 | The multiple acyl-coenzyme A dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic aciduria. Mitochondrial fatty acid oxidation, acyl-coenzyme A dehydrogenase, and electron transfer flavoprotein activities in fibroblasts |
| Q40655527 | The place of neuronal migration abnormalities in child neurology. |
| Q34661603 | Transient multiple acyl-CoA dehydrogenation deficiency in a newborn female caused by maternal riboflavin deficiency. |
Search more.